Probiotic‐induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory‐dependent mechanisms in a murine model of asthma
- 20 December 2006
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 37 (4), 498-505
- https://doi.org/10.1111/j.1365-2222.2006.02629.x
Abstract
Background Microbial intestinal colonization in early in life is regarded to play a major role for the maturation of the immune system. Application of non-pathogenic probiotic bacteria during early infancy might protect from allergic disorders but underlying mechanisms have not been analysed so far. Objective The aim of the current study was to investigate the immune effects of oral application of probiotic bacteria on allergen-induced sensitization and development of airway inflammation and airway hyper-reactivity, cardinal features of bronchial asthma. Methods Newborn Balb/c mice received orally 109 CFU every second day either Lactobacillus rhamnosus GG or Bifidobacterium lactis (Bb-12) starting from birth for consecutive 8 weeks, during systemic sensitization (six intraperitoneal injections, days 29–40) and airway challenge (days 54–56) with ovalbumin. Results The administration of either Bb-12 or LGG suppressed all aspects of the asthmatic phenotype: airway reactivity, antigen-specific immunoglobulin E production and pulmonary eosinophilia (mean: 137 vs. 17 and 13 cells × 103/mL, respectively). Antigen-specific recall proliferation by spleen cells and T-helper type 2 cytokine production (IL-4, IL-5 and IL-10) by mesenteric lymph node cells also showed significant reduction, while TGF production remained unchanged. Oral LGG administration particularly suppressed allergen-induced proliferative responses and was associated with an increase in numbers of TGF-β-secreting CD4+/CD3+ T cells in mesenteric lymph nodes (6.5, 16.7%) as well as nearly 2-fold up-regulation of Foxp3-expressing cells in peribronchial lymph nodes. Conclusions Neonatal application of probiotic bacteria inhibits subsequent allergic sensitization and airway disease in a murine model of asthma by induction of T regulatory cells associated with increased TGF-β production.Keywords
This publication has 44 references indexed in Scilit:
- Toll-like receptors—novel targets in allergic airway disease (probiotics, friends and relatives)European Journal of Pharmacology, 2006
- The ‘microflora hypothesis’ of allergic diseasesClinical and Experimental Allergy, 2005
- Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivityJournal of Allergy and Clinical Immunology, 2004
- Drug development strategies for asthma: in search of a new paradigmNature Immunology, 2004
- Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trialThe Lancet, 2003
- Immune responses to allergens early in life: when and why do allergies arise?Clinical and Experimental Allergy, 2002
- Allergy development and the intestinal microflora during the first year of lifeJournal of Allergy and Clinical Immunology, 2001
- Induction by a Lactic Acid Bacterium of a Population of CD4+T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10Clinical and Diagnostic Laboratory Immunology, 2001
- Is TGF-β1 the key to suppression of human asthma?Trends in Immunology, 2001
- Immune and Clinical Impact of Lactobacillus acidophilus on AsthmaAnnals of Allergy, Asthma & Immunology, 1997